- Home
- CWD vs SILO Comparison
CWD vs SILO Comparison
Compare CWD & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWD
- SILO
- Stock Information
- Founded
- CWD 2009
- SILO 2010
- Country
- CWD United States
- SILO United States
- Employees
- CWD N/A
- SILO N/A
- Industry
- CWD Real Estate
- SILO Apparel
- Sector
- CWD Finance
- SILO Consumer Discretionary
- Exchange
- CWD Nasdaq
- SILO Nasdaq
- Market Cap
- CWD 4.5M
- SILO 4.5M
- IPO Year
- CWD 2023
- SILO N/A
- Fundamental
- Price
- CWD $2.72
- SILO $0.70
- Analyst Decision
- CWD
- SILO
- Analyst Count
- CWD 0
- SILO 0
- Target Price
- CWD N/A
- SILO N/A
- AVG Volume (30 Days)
- CWD 42.7K
- SILO 489.0K
- Earning Date
- CWD 08-11-2025
- SILO 08-12-2025
- Dividend Yield
- CWD N/A
- SILO N/A
- EPS Growth
- CWD N/A
- SILO N/A
- EPS
- CWD N/A
- SILO N/A
- Revenue
- CWD $35,429,000.00
- SILO $72,102.00
- Revenue This Year
- CWD N/A
- SILO $1.86
- Revenue Next Year
- CWD $31.12
- SILO N/A
- P/E Ratio
- CWD N/A
- SILO N/A
- Revenue Growth
- CWD N/A
- SILO N/A
- 52 Week Low
- CWD $2.33
- SILO $0.41
- 52 Week High
- CWD $15.80
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- CWD 42.34
- SILO 60.14
- Support Level
- CWD $2.33
- SILO $0.55
- Resistance Level
- CWD $2.98
- SILO $0.72
- Average True Range (ATR)
- CWD 0.31
- SILO 0.06
- MACD
- CWD 0.01
- SILO 0.01
- Stochastic Oscillator
- CWD 37.87
- SILO 82.46
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.